• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗群体保护效果评估:从霍乱和伤寒疫苗试验中获得的经验教训。

Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials.

机构信息

Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines, Manila, Philippines.

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.

出版信息

J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S764-S769. doi: 10.1093/infdis/jiab358.

DOI:10.1093/infdis/jiab358
PMID:34273168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8687079/
Abstract

Vaccine herd protection is the extension of the defense conferred by immunization beyond the vaccinated to unvaccinated persons in a population, as well as the enhancement of the protection among the vaccinated, due to vaccination of the surrounding population. Vaccine herd protection has traditionally been inferred from observations of disease trends after inclusion of a vaccine in national immunization schedules. Rather than awaiting outcomes of widescale vaccine deployment, earlier-stage evaluation of vaccine herd protection during trials or mass vaccination projects could help inform policy decisions about potential vaccine introduction. We describe the components, influencing factors, and implications of vaccine herd protection and discuss various methods for assessing herd protection, using examples from cholera and typhoid vaccine studies.

摘要

疫苗群体保护是指通过免疫接种,将防御范围从接种者扩展到人群中的未接种者,以及由于周围人群的接种而增强接种者的保护。疫苗群体保护传统上是通过观察疫苗纳入国家免疫规划后疾病趋势的变化来推断的。在大规模疫苗部署之前,在试验或大规模疫苗接种项目中尽早评估疫苗群体保护,可以帮助为潜在疫苗引入的决策提供信息。我们描述了疫苗群体保护的组成部分、影响因素和意义,并讨论了使用霍乱和伤寒疫苗研究中的例子评估群体保护的各种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/8687079/ce3d496b687d/jiab358_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/8687079/ce3d496b687d/jiab358_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e560/8687079/ce3d496b687d/jiab358_fig1.jpg

相似文献

1
Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials.疫苗群体保护效果评估:从霍乱和伤寒疫苗试验中获得的经验教训。
J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S764-S769. doi: 10.1093/infdis/jiab358.
2
Effectiveness of vaccination against cholera and typhoid fever.霍乱和伤寒疫苗接种的有效性。
Monogr Allergy. 1975;9:217-30.
3
[Massive complex (combined) immunization against typhoid, cholera and plague].[针对伤寒、霍乱和鼠疫的大规模联合免疫接种]
Voen Med Zh. 1983 Aug(8):45-8.
4
[Intracutaneous vaccination technic with less side effects against typhoid and cholera].[预防伤寒和霍乱且副作用较小的皮内接种技术]
Duodecim. 1977;93(7):431-8.
5
[Experimental justification for combined subcutaneous immunization against cholera and typhoid fever].[霍乱和伤寒联合皮下免疫接种的实验依据]
Zh Mikrobiol Epidemiol Immunobiol. 1984 Jan(1):85-9.
6
Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.黄热病17D疫苗与口服减毒活霍乱CVD103-HgR疫苗和伤寒Ty21a疫苗的联合同时接种。
J Infect Dis. 1999 Feb;179(2):522-4. doi: 10.1086/314609.
7
Experience with registered mucosal vaccines.注册黏膜疫苗的经验。
Vaccine. 2003 Jan 30;21(7-8):678-83. doi: 10.1016/s0264-410x(02)00579-0.
8
Cholera and typhoid vaccine. The current state of play.霍乱和伤寒疫苗。当前的进展情况。
Aust Fam Physician. 1997 Aug;26(8):943-6.
9
A review of the current status of enteric vaccines.肠道疫苗现状综述
P N G Med J. 1995 Dec;38(4):325-31.
10
[Pertussis, typhoid-paratyphoid and cholera vaccines].[百日咳、伤寒-副伤寒和霍乱疫苗]
Bol Oficina Sanit Panam. 1973 Jan;74(1):23-35.

本文引用的文献

1
A guide to vaccinology: from basic principles to new developments.疫苗学指南:从基本原则到新进展。
Nat Rev Immunol. 2021 Feb;21(2):83-100. doi: 10.1038/s41577-020-00479-7. Epub 2020 Dec 22.
2
Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency.在高收入环境中,肺炎球菌疾病的血清型替代趋势不同,且多样性不断增加,这降低了扩大疫苗效价的获益。
Sci Rep. 2020 Nov 4;10(1):18977. doi: 10.1038/s41598-020-75691-5.
3
Re-evaluating herd protection by Vi typhoid vaccine in a cluster randomized trial.
在一项整群随机试验中重新评估 Vi 伤寒疫苗的群体保护效果。
Int Health. 2020 Jan 1;12(1):36-42. doi: 10.1093/inthealth/ihz069.
4
Assessing Vaccine Herd Protection by Killed Whole-Cell Oral Cholera Vaccines Using Different Study Designs.使用不同研究设计评估全细胞口服霍乱灭活疫苗的群体疫苗保护效果。
Front Public Health. 2019 Jul 31;7:211. doi: 10.3389/fpubh.2019.00211. eCollection 2019.
5
Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience.口服霍乱疫苗在控制疫情方面的进展和挑战:无国界医生组织的经验。
J Infect Dis. 2018 Oct 15;218(suppl_3):S165-S166. doi: 10.1093/infdis/jiy487.
6
Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance.伤寒结合疫苗:应对抗微生物药物耐药性的新工具。
Lancet Infect Dis. 2019 Jan;19(1):e26-e30. doi: 10.1016/S1473-3099(18)30350-5. Epub 2018 Aug 28.
7
Why does drug resistance readily evolve but vaccine resistance does not?为什么耐药性很容易产生,而疫苗抗性却不会呢?
Proc Biol Sci. 2017 Mar 29;284(1851). doi: 10.1098/rspb.2016.2562.
8
Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014.2014年南苏丹霍乱疫苗对流离失所人群的群体层面影响
Emerg Infect Dis. 2016 Jun;22(6):1067-70. doi: 10.3201/eid2206.151592.
9
A brief history of the cluster randomised trial design.整群随机试验设计简史。
J R Soc Med. 2015 May;108(5):192-8. doi: 10.1177/0141076815582303.
10
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.在桑给巴尔实施口服霍乱疫苗的效果:大规模疫苗接种运动和观察性队列研究的结果。
Lancet Infect Dis. 2012 Nov;12(11):837-44. doi: 10.1016/S1473-3099(12)70196-2. Epub 2012 Sep 4.